Skip to main content
Caplight Logo









Toro Neurovascular

Toro Neurovascular

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.toroneuro.com/

Last Round

Accelerator

Jun 5, 2025

Total Funding Raised

$3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Toro Neurovascular is a medical device company that develops advanced catheter technologies for the treatment of neurovascular diseases, including ischemic stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurovascular catheterthrombectomyischemic strokeaspiration catheterstroke interventionneurointerventionclot retrievalmedical deviceminimally invasive surgeryinterventional neuroradiologyneurovascular accessstroke careendovascular deviceneuro-interventional tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Toro Neurovascular Comparables

Compare Toro Neurovascular with similar companies based on industry and business-model similarity.

Toro Neurovascular comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ceretrieve
87%
Penumbra
82%
Imperative Care
81%

Toro Neurovascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
SeedJul 25, 2024

Key People

Founding team and executive leadership

Ryan Walker

Co-Founder & COO

Founding Team

Hyung Posalit

Founder & CEO

Founding Team

Toro Neurovascular Investors

Notable investors and investment history

Toro Neurovascular investors
InvestorRounds
MedTech InnovatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 30, 2026

    Grew 27% QoQ from 11 to 14 employees.

  • May 6, 2026

    Grew 71% QoQ, from 7 to 12 employees.

Toro Neurovascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Toro Neurovascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Toro Neurovascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersIrvine, California
Employee Range13
Year Founded2021
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?